Home › Schizophrenia › Nebraska › Lincoln
Schizophrenia clinical trials in Lincoln, NE
4 studies for Schizophrenia are looking for participants at sites in and around Lincoln (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Alivation Research LLC, Lincoln
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RecruitingPhase 3
- Local Institution - 0147, Lincoln
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
RecruitingObservational study
- Local Institution - 0041, Lincoln
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
RecruitingPhase 3
- Alkermes Investigator Site, Lincoln
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Houston, TX13 studies
- San Diego, CA13 studies
- Hialeah, FL13 studies
- New York City, NY13 studies
- Austin, TX13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in Lincoln
- Non-Small Cell Lung Cancer16 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Coronary Artery Disease5 studies
- Breast Cancer4 studies
- Obesity4 studies
- Colorectal Cancer4 studies
- Multiple Myeloma3 studies
- Melanoma3 studies
- Amyotrophic Lateral Sclerosis3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.